The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis

Saudi Journal of Gastroenterology

Volumn 21, Issue 4, 2015, Pages 208-212

  Peng, Jiang Chen ^a   Shen, Jun ^a   Zhu, Qi ^a   Ran, Zhi Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C. difficile infection; surgical risk; ulcerative colitis

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; IMMUNOSUPPRESSIVE AGENT;

CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COMORBIDITY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FECES CULTURE; HUMAN; META ANALYSIS; REVIEW; SURGICAL RISK; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; COMPLICATION; PEPTOCLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLECTOMY; COLITIS, ULCERATIVE; HUMANS;

EID: 84938379957     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.161644     Document Type: Review

References (42)

1. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin North Am 2009;38:711-28.
2. Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum 2009;52:40-5.
3. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic associated pseudomembranous colitis due to toxin producing clostridia. N Engl J Med 1978;298:531-4.
4. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-41.
5. Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008;103:1443-50.
6. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of clostridium difficile associated disease in Massachusetts hospitals: Clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28:1219-27.
7. Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:339-44.
8. Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:976-83.
9. Navaneethan U, Mukewar S, Venkatesh PG, Lopez R, Shen B. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis 2012;6:330-6.
10. Murthy SK, Steinhart AH, Tinmouth J, Austin PC, Daneman N, Nguyen GC. Impact of Clostridium difficile colitis on 5 year health outcomes in patients with ulcerative colitis. Aliment Pharmacol Ther 2012;36:1032-9.
11. Kariv R, Navaneethan U, Venkatesh PG, Lopez R, Shen B. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis 2011;5:34-40.
12. Kaneko T, Matsuda R, Taguri M, Inamori M, Ogura A, Miyajima E, et al. Clostridium difficile infection in patients with ulcerative colitis: Investigations of risk factors and efficacy of antibiotics for steroid refractory patients. Clin Res Hepatol Gastroenterol 2011;35:315-20.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta analysis of observational studies in epidemiology: A proposal for reporting. Meta analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
14. DerSimonian R, Laird N. Meta analysis in clinical trials. Control Clin Trials 1986;7:177-88.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta analysis. Stat Med 2002;21:1539-58.
16. Reddy SS, Brandt LJ. Clostridium difficile Infection and Inflammatory Bowel Disease. J Clin Gastroenterol 2013;47:666-71.
17. Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile Infection in children. JAMA Pediatr 2013;167:567-73.
18. Campbell R, Dean B, Nathanson B, Haidar T, Strauss M, Thomas S. Length of stay and hospital costs among high risk patients with hospital origin Clostridium difficile associated diarrhea. J Med Econ 2013;16:440-8.
19. Hsu CH, Jeng YM, Ni YH. Clostridium difficile infection in a patient with Crohn disease. J Formos Med Assoc 2012;111:347-9.
20. Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis 2013;19:194-204.
21. Ananthakrishnan AN, Guzman Perez R, Gainer V, Cai T, Churchill S, Kohane I, et al. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:789-95.
22. Mezoff E, Mann EA, Hart KW, Lindsell CJ, Cohen MB. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population. J Pediatr Gastroenterol Nutr 2011;52:437-41.
23. Ott C, Girlich C, Klebl F, Plentz A, Iesalnieks I, Scholmerich J, et al. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center. Digestion 2011;84:187-92.
24. Sinh P, Barrett TA, Yun L. Clostridium difficile Infection and Inflammatory Bowel Disease: A Review. Gastroenterol Res Pract 2011;2011:136064.
25. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin North Am 2010;94:135-53.
26. Musa S, Thomson S, Cowan M, Rahman T. Clostridium difficile infection and inflammatory bowel disease. Scand J Gastroenterol 2010;45:261-72.
27. Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: Understanding the evolving relationship. World J Gastroenterol 2010;16:4892-904.
28. Sonnenberg A. Similar geographic variations of mortality and hospitalization associated with IBD and Clostridium difficile colitis. Inflamm Bowel Dis 2010;16:487-93.
29. Wultanska D, Banaszkiewicz A, Radzikowski A, Obuch Woszczatynski P, Mlynarczyk G, Brazier JS, et al. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. Eur J Clin Microbiol Infect Dis 2010;29:1265-70.
30. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008;179:767-72.
31. Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009;154:854-8.
32. Ananthakrishnan AN, McGinley EL. Infection related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis 2013;7:107-12.
33. Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:345-51.
34. Jen MH, Saxena S, Bottle A, Aylin P, Pollok RC. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:1322-31.
35. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008;57:205-10.
36. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co existing Clostridium difficile infection. Dig Dis Sci 2010;55:415-20.
37. Navaneethan U, Giannella RA. Thinking beyond the colon small bowel involvement in Clostridium difficile infection. Gut Pathog 2009;1:7.
38. Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 2006;44:2785-91.
39. LaMont JT, Trnka YM. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet 1980;1:381-3.
40. Shen BO, Jiang ZD, Fazio VW, Remzi FH, Rodriguez L, Bennett AE, et al. Clostridium difficile infection in patients with ileal pouch anal anastomosis. Clin Gastroenterol Hepatol 2008;6:782-8.
41. Lundeen SJ, Otterson MF, Binion DG, Carman ET, Peppard WJ. Clostridium difficile enteritis: An early postoperative complication in inflammatory bowel disease patients after colectomy. J Gastrointest Surg 2007;11:138-42.
42. Ben Horin S, Margalit M, Bossuyt P, Maul J, Shapira Y, Bojic D, et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol 2009;7:981-7.